ATE461172T1 - Azetidinderivate als antagonisten des muskarinrezeptors - Google Patents

Azetidinderivate als antagonisten des muskarinrezeptors

Info

Publication number
ATE461172T1
ATE461172T1 AT07804896T AT07804896T ATE461172T1 AT E461172 T1 ATE461172 T1 AT E461172T1 AT 07804896 T AT07804896 T AT 07804896T AT 07804896 T AT07804896 T AT 07804896T AT E461172 T1 ATE461172 T1 AT E461172T1
Authority
AT
Austria
Prior art keywords
antagonists
muscariine
receptor
azetidine derivatives
azetidine
Prior art date
Application number
AT07804896T
Other languages
English (en)
Inventor
Paul Glossop
Ross Strang
Christine Watson
Anthony Wood
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Application granted granted Critical
Publication of ATE461172T1 publication Critical patent/ATE461172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07804896T 2006-09-22 2007-09-04 Azetidinderivate als antagonisten des muskarinrezeptors ATE461172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82662906P 2006-09-22 2006-09-22
PCT/IB2007/002593 WO2008035157A1 (en) 2006-09-22 2007-09-04 Azetidine derivatives as muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
ATE461172T1 true ATE461172T1 (de) 2010-04-15

Family

ID=39046833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07804896T ATE461172T1 (de) 2006-09-22 2007-09-04 Azetidinderivate als antagonisten des muskarinrezeptors

Country Status (8)

Country Link
US (1) US20100160279A1 (de)
EP (1) EP2066626B1 (de)
JP (1) JP2010504316A (de)
AT (1) ATE461172T1 (de)
CA (1) CA2664057A1 (de)
DE (1) DE602007005387D1 (de)
ES (1) ES2340220T3 (de)
WO (1) WO2008035157A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364727T3 (es) * 2007-03-16 2011-09-13 Pfizer Limited Sal clorhidrato de 5-[3-(3-hidroxifenoxi)azetidin-1-il]-5-metil-2,2-difenilhexanamida.
KR101577159B1 (ko) 2008-07-31 2015-12-11 세노믹스, 인코포레이티드 단맛 향상제의 제조 방법 및 중간체
JP5801997B2 (ja) 2009-07-07 2015-10-28 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器
SG11202100846YA (en) 2018-08-07 2021-02-25 Firmenich Incorporated 5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
US20230293430A1 (en) 2020-06-26 2023-09-21 Mylan Pharma Uk Limited Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4167302B2 (ja) * 1996-12-02 2008-10-15 杏林製薬株式会社 新規ｎ―置換ピロリジン誘導体及びその製造法
JPH11100366A (ja) * 1997-09-29 1999-04-13 Kyorin Pharmaceut Co Ltd 新規ｎ−置換環状アミン誘導体及びその製造法
SI1928821T1 (sl) * 2005-09-21 2009-04-30 Pfizer Ltd Derivati karboksamida kot antagonisti muskarinskih receptorjev

Also Published As

Publication number Publication date
DE602007005387D1 (de) 2010-04-29
CA2664057A1 (en) 2008-03-27
US20100160279A1 (en) 2010-06-24
EP2066626B1 (de) 2010-03-17
JP2010504316A (ja) 2010-02-12
WO2008035157A1 (en) 2008-03-27
EP2066626A1 (de) 2009-06-10
ES2340220T3 (es) 2010-05-31

Similar Documents

Publication Publication Date Title
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
EA200900658A1 (ru) Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами
MX2010008375A (es) Derivados de piperidina espirocíclicos substituidos como ligandos de receptores de histamina-3 (h3).
EA200970156A1 (ru) Пиридизиноновые производные
CR10922A (es) Derivados de indol como antagonistas receptores de s1p1
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
JO2770B1 (en) Organic compounds
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
TW200745122A (en) New compounds I
MY150062A (en) Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
MA32479B1 (fr) Compoés nouveaux actifs comme antagonistes des recepteurs muscariniques
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors
EA201000703A1 (ru) Производные пиразола в качестве ингибиторов 5-lo
TW200745133A (en) New compounds II
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
WO2009034432A8 (en) Novel compounds active as muscarinic receptor antagonists
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
ATE482195T1 (de) Benzoäfüisoindole als antagonisten des ep4- rezeptors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties